Vancouver, British Columbia – September 22, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) is pleased to provide shareholders with a link to a recent round table discussion on skin lighteners. Chief Business Development Officer, Attila Hajdu, participated in the discussion, which was produced by ComCap Media.
https://www.youtube.com/watch?v=fbZLFVlPI8g
About ComCap Media
ComCap Media is a new, unique financial platform that focuses on providing compact financial news with high quality content. The platform is covering small and midcaps with significant upside potential from all over the world. For more information about ComCap Media - http://comcap.media/
For more information regarding this announcement, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
About Sirona Biochem
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France. The company specializes in the stabilization of carbohydrate molecules, with the goal of improving compounds’ efficacy and safety. Sirona Biochem’s compounds are patented as new chemical entities for maximum commercial protection and revenue potential. Newly developed compounds are licensed to leading companies around the world in return for licensing and milestone fees and ongoing royalty payments. TFChem, Sirona Biochem’s wholly-owned French laboratory is a recipient of multiple French national scientific awards and a European Union and French government grant. For more information visit www.sironabiochem.com
